Infectious disease · Phase III

Top sponsors

• United Therapeutics Europe 22 programs
• GSK Glaxo Smith 20 programs
• BRIGHT MINDS BIOSCIENCES 18 programs
• Chinese Academy of 13 programs
• Takeda 12 programs
• Sinovac Research and 11 programs
• Gilead Sciences Ireland 10 programs
• PARItec 10 programs
• Gilead Sciences 9 programs
• Pfizer 8 programs
• Vir Biotechnology 7 programs
• George Institute for 6 programs

1. TAK-339-3001

   Takeda

   Primary infection prophylaxis for secondary immunodeficiency (SID) in patients with multiple myeloma (MM) receiving B cell maturation antigen (BCMA)-directed bispecific (BsAb) therapy

   phase 3 · small molecule · active

   1 trial →

2. TAK-438

   Takeda

   H. Pylori Infection

   phase 3 · small molecule · completed

   1 trial →

3. TAK-620-2004

   Takeda

   Cytomegalovirus (CMV) infection in children and adolescents who have received a hematopoietic stem cell transplant (HSCT) or a solid organ transplant (SOT)

   phase 3 · small molecule · active

   1 trial →

4. TBP-PI-HBr

   Spero Therapeutics

   Urinary Tract Infection

   phase 3 · small molecule · completed

   1 trial →

5. TBPM-PI-HBr

   Spero Therapeutics

   Complicated Urinary Tract Infection

   phase 3 · small molecule · completed

   1 trial →

6. TMC125

   Elan Pharma International

   HIV-1

   phase 3 · small molecule · completed

   1 trial →

7. TPO

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Sepsis

   phase 3 · small molecule · active

   1 trial →

8. Tafenoquine

   GlaxoSmithKline

   Malaria, Vivax

   phase 3 · small molecule · completed

   2 trials →

9. Tedizolid (BAY119-2631)

   Bayer HealthCare AG

   Bacterial Infections

   phase 3 · small molecule · completed

   1 trial →

10. Telaprevir

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatitis C, Chronic

    phase 3 · small molecule · terminated

    2 trials →

11. Telavancin

    CUMBERLAND PHARMACEUTICALS INC

    Bacterial Pneumonia

    phase 3 · small molecule · completed

    2 trials →

12. Telavancin

    CUMBERLAND PHARMACEUTICALS INC

    Staphylococcal Skin Infection

    phase 3 · small molecule · completed

    2 trials →

13. Telbivudine

    Novartis Pharmaceuticals

    Hepatitis

    phase 3 · small molecule · completed

    1 trial →

14. Tenofovir DF

    Gilead Sciences Ireland UC

    Chronic Hepatitis B

    phase 3 · small molecule · active

    1 trial →

15. Tenofovir gel

    United Therapeutics Europe Ltd

    HIV Prevention

    phase 3 · small molecule · completed

    1 trial →

16. Tice® BCG (for intravesical use) BCG LIVE strain of the BCG (Merck) vaccine

    United Therapeutics Europe Ltd

    COVID-19

    phase 3 · small molecule · terminated

    1 trial →

17. Tissue Plasminogen Activator

    Chinese University of Hong Kong

    Pleural Infection

    phase 3 · small molecule · active

    1 trial →

18. Tobevibart

    Vir Biotechnology

    Viral Hepatitis

    phase 3 · small molecule · active

    3 trials →

19. Tobramycin Injection

    United Therapeutics Europe Ltd

    Wound Infection

    phase 3 · small molecule · active

    1 trial →

20. Tozorakimab

    AstraZeneca

    Viral Lung Infection and Acute Respiratory Failure

    phase 3 · small molecule · active

    1 trial →

21. Tozorakimab, Tozorakimab-placebo

    AstraZeneca AB

    Severe viral lung infections

    phase 3 · small molecule · active

    1 trial →

22. Tradipitant

    Vanda Pharmaceuticals Netherlands B.V.

    Coronavirus Infection

    phase 3 · small molecule · active

    1 trial →

23. Traditional Chinese Medicine Prescription

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 3 · small molecule · active

    1 trial →

24. Treatment group

    United Therapeutics Europe Ltd

    Post Operative Surgical Site Infection

    phase 3 · small molecule · completed

    1 trial →

25. Triplitode

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    AIDS/HIV PROBLEM

    phase 3 · small molecule · active

    1 trial →

26. Triptolide Wilfordii

    Peking University Third Hospital

    HIV-infection/AIDS

    phase 3 · small molecule · completed

    1 trial →

27. Truvada

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 3 · small molecule · completed

    1 trial →

28. UB-421

    United Therapeutics Europe Ltd

    HIV-1 Infection

    phase 3 · mab · active

    4 trials →

29. V114

    Merck KGaA, Darmstadt, Germany

    Pneumococcal Infections

    phase 3 · mab · completed

    1 trial →

30. V503-021

    Merck Sharp and Dohme

    ​9vHPV vaccine is indicated in females ≥ 9 years of age in the prevention of cervical, vulvar, vaginal, and anal cancer; precancerous or dysplastic lesions; and persistent infections caused by Human Papillomavirus (HPV) types 16, 18, 31, 33, 45, 52, and 58, and genital warts (condyloma acuminata) caused by HPV types 6 and 11.​

    phase 3 · small molecule · active

    1 trial →

31. VACAB-2022

    The George Institute

    Patients with hip or knee infections

    phase 3 · small molecule · active

    1 trial →

32. VIR-3434, VIR-2218

    Vir Biotechnology

    Chronic Hepatitis D Virus (HDV) Infection

    phase 3 · small molecule · active

    1 trial →

33. VIR-7831

    Vir Biotechnology

    COVID-19

    phase 3 · mab · completed

    1 trial →

34. VIR-7831 (sotrovimab)

    Vir Biotechnology

    Covid19

    phase 3 · mab · completed

    1 trial →

35. VIR-CHDV-V205

    Vir Biotechnology

    Chronic Hepatitis D Virus (HDV) Infection

    phase 3 · small molecule · active

    1 trial →

36. Vitamin A

    United Therapeutics Europe Ltd

    Sepsis

    phase 3 · other · completed

    1 trial →

37. Vonoprazan

    Phathom Pharmaceuticals

    Helicobacter Pylori Infection

    phase 3 · small molecule · completed

    1 trial →

38. Yinhu Qingwen Granula

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 3 · small molecule · on hold

    1 trial →

39. Ypeginterferon alfa-2b

    The First People's Hospital of Lianyungang

    Chronic Hepatitis B

    phase 3 · small molecule · completed

    3 trials →

40. abamectin and fenpyroximate

    United Therapeutics Europe Ltd

    Malaria

    phase 3 · small molecule · terminated

    1 trial →

41. alpha1-proteinase inhibitor

    Takeda

    Covid19

    phase 3 · small molecule · terminated

    1 trial →

42. bLF (Bovine lactoferrin)

    United Therapeutics Europe Ltd

    Neonatal Sepsis

    phase 3 · other · active

    1 trial →

43. behavior intervention and male circumcision

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HIV

    phase 3 · other · active

    1 trial →

44. cART(TDF/AZT+3TC+LPV/r)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute HIV Infection

    phase 3 · small molecule · active

    1 trial →

45. casirivimab+imdevimab combination therapy

    Regeneron UK Limited

    COVID-19

    phase 3 · small molecule · terminated

    1 trial →

46. daclatasvir

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis C

    phase 3 · small molecule · completed

    1 trial →

47. eltrombopag

    GlaxoSmithKline

    Hepatitis C, Chronic

    phase 3 · small molecule · completed

    1 trial →

48. ganciclovir

    Ultragenyx UK Limited

    Cytomegalovirus Infections

    phase 3 · small molecule · completed

    1 trial →

Frequently asked questions